Nuritas

company

About

Nuritas combines artificial intelligence and genomics to discover and unlock natural bioactive peptides with extraordinary health benefits

  • 11 - 50

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
€30M
Industries
Artificial Intelligence,Bioinformatics,Biotechnology,Data Mining
Founded date
Jan 1, 2014
Number Of Employee
11 - 50
Operating Status
Active

Nuritas is revolutionising the discovery of novel, natural and scientifically proven active ingredients that can manage and improve human health. The company’s disruptive computational approach to discovery uses artificial intelligence and genomics to, for the first time ever, rapidly and efficiently predict and then provide access to the most health-benefiting components hidden within food, called bioactive peptides.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
€30M
Nuritas has raised a total of €30M in funding over 2 rounds. Their latest funding was raised on Nov 30, 2018 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 30, 2018 Debt Financing €30M 1 European Investment Bank Detail
Jan 1, 2015 Series Unknown 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
2
Nuritas is funded by 2 investors. European Investment Bank and Keiretsu Forum are the most recent investors.
Investor Name Lead Investor Funding Round
European Investment Bank Yes Debt Financing
Keiretsu Forum Series Unknown